Anthem Inc (A58) - Total Assets
Based on the latest financial reports, Anthem Inc (A58) holds total assets worth €121.49 Billion EUR as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anthem Inc - Total Assets Trend (2015–2025)
This chart illustrates how Anthem Inc's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Anthem Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Anthem Inc's total assets of €121.49 Billion consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 7.8% |
| Accounts Receivable | €10.07 Billion | 8.3% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €11.20 Billion | 9.2% |
| Goodwill | €28.34 Billion | 23.3% |
Asset Composition Trend (2015–2025)
This chart illustrates how Anthem Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anthem Inc's current assets represent 0.0% of total assets in 2025, a decrease from 50.0% in 2015.
- Cash Position: Cash and equivalents constituted 7.8% of total assets in 2025, up from 3.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, a decrease from 41.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 23.3% of total assets.
Anthem Inc Competitors by Total Assets
Key competitors of Anthem Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Healthconn Corp.
TWO:6665
|
Taiwan | NT$1.54 Billion |
|
CLOVER HEALTH INV. CL.A
F:7QD
|
Germany | €541.01 Million |
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
USA | $1.07 Billion |
|
Cigna Corp
NYSE:CI
|
USA | $157.92 Billion |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
USA | $541.01 Million |
|
Centene Corp
NYSE:CNC
|
USA | $76.75 Billion |
|
CarePayment Technologies Inc
PINK:CPYT
|
USA | $10.24 Million |
|
CVS Health Corp
NYSE:CVS
|
USA | $261.06 Billion |
Anthem Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.41 | 1.35 | 1.56 |
| Quick Ratio | 1.41 | 1.35 | 1.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €17.85 Billion | €14.32 Billion | €12.36 Billion |
Anthem Inc - Advanced Valuation Insights
This section examines the relationship between Anthem Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.48 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | €121.49 Billion |
| Market Capitalization | $60.83 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Anthem Inc's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Anthem Inc's assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Anthem Inc (2015–2025)
The table below shows the annual total assets of Anthem Inc from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €121.49 Billion | +3.94% |
| 2024-12-31 | €116.89 Billion | +7.31% |
| 2023-12-31 | €108.93 Billion | +5.99% |
| 2022-12-31 | €102.77 Billion | +5.62% |
| 2021-12-31 | €97.31 Billion | +12.34% |
| 2020-12-31 | €86.61 Billion | +11.83% |
| 2019-12-31 | €77.45 Billion | +8.22% |
| 2018-12-31 | €71.57 Billion | +1.46% |
| 2017-12-31 | €70.54 Billion | +8.38% |
| 2016-12-31 | €65.08 Billion | +5.45% |
| 2015-12-31 | €61.72 Billion | -- |
About Anthem Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more